Literature DB >> 9028633

Light microscope autoradiography of peripheral dopamine receptor subtypes.

F Amenta1.   

Abstract

Radioligand binding assay techniques associated with light microscope autoradiography were used for investigating the pharmacological profile and the micro anatomical localization of peripheral dopamine receptor subtypes. In systemic arteries, the predominant dopamine D1-like receptor belongs to the D5 (or D1B) subtype. It is located within smooth muscle of the tunica media. In pulmonary arteries, dopamine D1-like receptors have primarily an endothelial localization and belong to the dopamine D1 (or D1A) receptor subtype. Both systemic and pulmonary arteries express a dopamine D2-like receptor belonging to the D2 receptor subtype. It has a prejunctional localization in the majority of vascular beds investigated. In cerebral, coronary and mesenteric arteries, it has also an endothelial localization. In the heart, a dopamine D4 receptor was identified. It is expressed by atrial tissue and has a widespread distribution overall atrial musculature. The kidney expresses both dopamine D1-like and D2-like receptors. Renal dopamine D1-like receptors have a vascular and tubular localization. The majority of these sites belongs to the D5 receptor subtype. A smaller D1 receptor population has primarily a tubular localization. Renal dopamine D2-like receptors belong to the dopamine D3 subtype and in lesser amounts to the D2 and D4 receptor subtypes. Renal dopamine D3 receptor has to a greater extent a tubular localization, whereas the D4 receptor is located within glomerular arterioles. The above results suggest that radioligand binding assay and autoradiographic techniques, if performed in the presence of compounds displaying specific receptor subtype selectivity, may contribute to characterize, mainly from a quantitative point of view, peripheral dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9028633     DOI: 10.3109/10641969709080802

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  7 in total

Review 1.  Potential dopamine-1 receptor stimulation in hypertension management.

Authors:  Mohammad Asghar; Seyed K Tayebati; Mustafa F Lokhandwala; Tahir Hussain
Journal:  Curr Hypertens Rep       Date:  2011-08       Impact factor: 5.369

2.  Lack of renal dopamine D5 receptors promotes hypertension.

Authors:  Laureano Asico; Xiaojie Zhang; Jifu Jiang; David Cabrera; Crisanto S Escano; David R Sibley; Xiaoyan Wang; Yu Yang; Roslyn Mannon; John E Jones; Ines Armando; Pedro A Jose
Journal:  J Am Soc Nephrol       Date:  2010-11-04       Impact factor: 10.121

Review 3.  Dopamine, kidney, and hypertension: studies in dopamine receptor knockout mice.

Authors:  Xiaoyan Wang; Van Anthony M Villar; Ines Armando; Gilbert M Eisner; Robin A Felder; Pedro A Jose
Journal:  Pediatr Nephrol       Date:  2008-07-10       Impact factor: 3.714

Review 4.  Reactive oxygen species and dopamine receptor function in essential hypertension.

Authors:  Chunyu Zeng; Van Anthony M Villar; Peiying Yu; Lin Zhou; Pedro A Jose
Journal:  Clin Exp Hypertens       Date:  2009-04       Impact factor: 1.749

Review 5.  Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice.

Authors:  Chunyu Zeng; Ines Armando; Yingjin Luo; Gilbert M Eisner; Robin A Felder; Pedro A Jose
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-12-14       Impact factor: 4.733

6.  Endothelium-derived dopamine modulates EFS-induced contractions of human umbilical vessels.

Authors:  José Britto-Júnior; David H A Pinheiro; Alberto F O Justo; Guilherme M Figueiredo Murari; Rafael Campos; Fernanda V Mariano; Valéria B de Souza; André A Schenka; Fabiola Z Mónica; Edson Antunes; Gilberto De Nucci
Journal:  Pharmacol Res Perspect       Date:  2020-08

Review 7.  Dopamine Receptors and the Kidney: An Overview of Health- and Pharmacological-Targeted Implications.

Authors:  Alejandro Olivares-Hernández; Luis Figuero-Pérez; Juan Jesus Cruz-Hernandez; Rogelio González Sarmiento; Ricardo Usategui-Martin; José Pablo Miramontes-González
Journal:  Biomolecules       Date:  2021-02-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.